Remus Pharmaceuticals Q2 Results
- BSE: -
- NSE: REMUS
- ISIN: INE0O5T01011
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
775
28.10 (3.76%)
28.10 (3.76%)Volume7.20 K
Updated: Fri 8 May, 2026 | 14:13:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹400.20 Cr.(46.76%)
- Operating Profit₹25.62 Cr.(27.29%)
- Profit After Tax₹17.50 Cr.(24.90%)
- Operating Margin6.40%(-78.98%)
Note: Comparison is on YoY basis
Quarterly - Remus Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | - | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 374.58 | - | N/A | 20.19 | 48.31% |
| Depreciation/ Amortization | 1.29 | - | N/A | 0.42 | 239.03% |
| Operating Income | 25.62 | - | N/A | 8.85 | 27.29% |
| Net Income | 17.50 | - | N/A | 5.65 | 24.90% |
| Other Operating Expenses Total | 17.53 | - | N/A | 2.88 | 21.39% |
| Net Income Before Taxes | 27.90 | - | N/A | 10.41 | 25.26% |
| Total Revenue | 400.20 | - | N/A | 29.04 | 46.76% |
| Selling/ General/ Admin Expenses Total | 6.22 | - | N/A | 3.29 | 5.68% |
| Diluted Normalized EPS | 18.33 | - | N/A | 5.19 | 54.16% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.